Physician

David Jordan Fitzhugh, M.D.

According to 2025 Medicare claims, David Fitzhugh, M.D. (NPI: 1962627547) practices allergy/immunology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Orange, NC. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1720344047; TIN: 561249571) and primary practice location at 27514-5278. Fitzhugh is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Fitzhugh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 91 traditional Medicare patients, billed 6,037 HCPCS/CPT codes, and received $129,731 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 456 prescription claims across 78 beneficiaries totaling $768,210 in drug costs, led by Haegarda (C1 Esterase Inhibitor). DME data shows 78 claims. Open Payments data shows 79 records totaling $36,948. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,192 to $129,731. Similarly, Part D prescription costs have risen steadily, from $21,485 to $768,210. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	43	1,164	$14,192
2016	51	1,469	$18,884
2017	69	1,516	$21,111
2018	65	1,815	$27,604
2019	70	2,203	$39,659
2020	68	2,573	$56,096
2021	77	1,961	$33,626
2022	87	2,492	$56,925
2023	90	5,456	$126,054
2024	91	6,037	$129,731

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	124	$21,485
2016	40	177	$667,437
2017	56	309	$782,779
2018	56	287	$510,373
2019	72	372	$629,562
2020	70	376	$683,143
2021	84	402	$712,585
2022	81	408	$874,323
2023	69	421	$738,332
2024	78	456	$768,210

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	39	$29,957
2022	N/R	36	$28,658
2023	N/R	44	$30,063
2024	N/R	78	$103,956

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	26	26	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	26	33	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	20	22	$44
95165	Professional service for preparation and provision of 1 or more antigens	18	365	$9
95117	Professional service for multiple injections of allergen	24	203	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Haegarda	C1 Esterase Inhibitor	12	336	$504,420
Dupixent Pen	Dupilumab	16	448	$61,820
Dupixent Syringe	Dupilumab	14	392	$52,388
Xolair	Omalizumab	14	392	$34,181
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	990	$20,432

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$69,003
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	13	$33,119
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	26	$1,500
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	26	$334

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$36,948	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Jordan Fitzhugh, M.D.?

Tedicare shows public-source Medicare data for David Jordan Fitzhugh, M.D. (NPI 1962627547), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Jordan Fitzhugh, M.D. have ACO affiliation data?

David Jordan Fitzhugh, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to David Jordan Fitzhugh, M.D.?

David Jordan Fitzhugh, M.D. is linked to ALLERGY PARTNERS, PLLC (billing NPI 1720344047) in the available physician profile data.

Does David Jordan Fitzhugh, M.D. have Open Payments data?

David Jordan Fitzhugh, M.D. has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.